AACR logo

More articles from Therapeutic Discovery

Telomere Targeting with a New G4 Ligand Enhances Radiation-Induced Killing of Human Glioblastoma Cells
Patrick Merle, Bertrand Evrard, Anne Petitjean, Jean-Marie Lehn, Marie-Paule Teulade-Fichou, Emmanuel Chautard, Anne De Cian, Lionel Guittat, Phong Lan Thao Tran, Jean-Louis Mergny, Pierre Verrelle, Andreï Tchirkov

Molecular Cancer Therapeutics Oct 2011, 10 (10) 1784-1795; DOI: 10.1158/1535-7163.MCT-10-0664
Novel Irreversible Small Molecule Inhibitors of Replication Protein A Display Single-Agent Activity and Synergize with Cisplatin
Tracy M. Neher, Diane Bodenmiller, Richard W. Fitch, Shadia I. Jalal, John J. Turchi

Molecular Cancer Therapeutics Oct 2011, 10 (10) 1796-1806; DOI: 10.1158/1535-7163.MCT-11-0303
Antitumor Activity of a Recombinant Soluble Ectodomain of Mutant Human Fibroblast Growth Factor Receptor-2 IIIc
Ju Wang, Xue-ting Liu, Hui Huang, Gang Xiao, Zhi-you Zhou, Yang Chen, Zhi-hong Yu, Shui-lian He, An-an Chen, Ding-ding Wang, Ying He, Zhi-cheng Zhang, An Hong

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1656-1666; DOI: 10.1158/1535-7163.MCT-11-0163
Nerve Growth Factor Links Oral Cancer Progression, Pain, and Cachexia
Yi Ye, Dongmin Dang, Jianan Zhang, Chi T. Viet, David K. Lam, John C. Dolan, Jennifer L. Gibbs, Brian L. Schmidt

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1667-1676; DOI: 10.1158/1535-7163.MCT-11-0123
Human Monoclonal Antibody Fragments Binding to Insulin-like Growth Factors I and II with Picomolar Affinity
Qi Zhao, Yang Feng, Zhongyu Zhu, Dimiter S. Dimitrov

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1677-1685; DOI: 10.1158/1535-7163.MCT-11-0281
Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
Per Lund, Irina Kotova, Valérie Kedinger, Harshal Khanwalkar, Emilie Voltz, William C. Hahn, Hinrich Gronemeyer

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1611-1623; DOI: 10.1158/1535-7163.MCT-11-0140
Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
Frédéric R. Santer, Philipp P.S. Höschele, Su Jung Oh, Holger H.H. Erb, Jan Bouchal, Ilaria T. Cavarretta, Walther Parson, David J. Meyers, Philip A. Cole, Zoran Culig

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1644-1655; DOI: 10.1158/1535-7163.MCT-11-0182
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone–Regulated Tumors
Daria Leali, Patrizia Alessi, Daniela Coltrini, Roberto Ronca, Michela Corsini, Giorgia Nardo, Stefano Indraccolo, Marco Presta

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1600-1610; DOI: 10.1158/1535-7163.MCT-11-0286
Potent, Selective Inhibitors of Fibroblast Growth Factor Receptor Define Fibroblast Growth Factor Dependence in Preclinical Cancer Models
Matthew Squires, George Ward, Gordan Saxty, Valerio Berdini, Anne Cleasby, Peter King, Patrick Angibaud, Tim Perera, Lynsey Fazal, Douglas Ross, Charlotte Griffiths Jones, Andrew Madin, Rajdeep K. Benning, Emma Vickerstaffe, Alistair O'Brien, Martyn Frederickson, Michael Reader, Christopher Hamlett, Michael A. Batey, Sharna Rich, Maria Carr, Darcey Miller, Ruth Feltell, Abarna Thiru, Susanne Bethell, Lindsay A. Devine, Brent L. Graham, Andrew Pike, Jose Cosme, Edward J. Lewis, Eddy Freyne, John Lyons, Julie Irving, Christopher Murray, David R. Newell, Neil T. Thompson

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1542-1552; DOI: 10.1158/1535-7163.MCT-11-0426
Inhibition of Dynamin by Dynole 34-2 Induces Cell Death following Cytokinesis Failure in Cancer Cells
Megan Chircop, Swetha Perera, Anna Mariana, Hui Lau, Maggie P.C. Ma, Jayne Gilbert, Nigel C. Jones, Christopher P. Gordon, Kelly A. Young, Andrew Morokoff, Jennette Sakoff, Terence J. O'Brien, Adam McCluskey, Phillip J. Robinson

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1553-1562; DOI: 10.1158/1535-7163.MCT-11-0067

Main menu

User menu

Search

More articles from Therapeutic Discovery

Pages

Articles

Info for

About MCT